Medication-Assisted Treatment (MAT) Centers in Mississippi

Yes. Providers in Mississippi must document a current OUD diagnosis to prescribe mat as part of medication-assisted treatment. The intake assessment typically takes 60–90 minutes and includes a physical exam, drug screen, and psychiatric history — results are used to confirm eligibility.

Vivitrol monthly cost without insurance typically falls between $1,100 and $1,500 per injection in Mississippi. The manufacturer Alkermes offers a patient-assistance co-pay savings card; state-funded programs also cover Vivitrol for uninsured patients in many counties.

Mississippi Medicaid copays for MAT visits are typically $0–$3, and are often waived for patients with behavioral-health conditions. Pharmacy copays for buprenorphine or naltrexone prescriptions follow the same schedule.

You may owe the full charge minus any out-of-network benefit. Ask MAT programs whether they will file an insurance claim, charge you up-front, or negotiate a single-case agreement with your insurer. No Surprises Act protections may apply — request a Good Faith Estimate.

Mississippi’s Good Samaritan law provides immunity from low-level drug-possession prosecution when someone seeks help for an overdose. MAT enrollment is not penalized; Mississippi specifically prohibits probation or family court from forcing patients to stop mat.

Many Mississippi patients stay on mat for a year or more, and some stay indefinitely. Duration depends on individual stability, quality of life, and risk of relapse. Research consistently shows that longer MAT duration is associated with lower overdose mortality.

Use the SAMHSA treatment locator at findtreatment.gov, filter by Mississippi, and search for medications offered. You can also browse our directory of MAT programs filtered to Mississippi, or call 988 for live referrals from a trained counselor.

A positive urine drug screen is expected for most patients entering MAT — it confirms the diagnosis. Positive screens are not used to deny admission at any Mississippi SAMHSA-certified OTP. Your clinician interprets results and builds an individualized plan from there.

Combining alcohol with methadone or buprenorphine increases sedation and respiratory-depression risk; avoidance is strongly recommended. Naltrexone treats alcohol use disorder directly and is not impaired by occasional drinking, but heavy drinking can still cause liver harm. Be honest about use with your Mississippi clinician.

Yes. Starting MAT during pregnancy is strongly recommended for patients with OUD. Mississippi perinatal-addiction programs offer priority same-day access; OB-MAT coordinated care improves maternal and infant outcomes dramatically compared to untreated OUD.

No — counselors with master’s-level licensure (LCSW, LPC, LMFT) provide therapy but do not prescribe medication. A nurse practitioner, physician assistant, or physician on the Mississippi MAT team handles the prescription. Counselor and prescriber collaborate on your care plan.

Improper disclosure of your records under 42 CFR Part 2 can be grounds for federal complaint and civil damages. File complaints with SAMHSA, the HHS Office of Civil Rights, and Mississippi’s behavioral-health licensing agency. An attorney can advise on civil remedies.